Kintara TherapeuticsKTRA 
$4.380.00%24h
0.00%24h
Global rank5042
Market cap$7.10M
Change 7d-25.64%
YTD Performance2587.12%
SP500 benchmarkOutperform
P/E-0.47
P/S0
Revenue$0
Earnings-$14.65M
Dividend yield-
Main Sector
Healthcare
Category
EPS for Kintara Therapeutics (KTRA)
Kintara Therapeutics has an EPS of $-9.27. In 2022, the company made an earnings per share (EPS) of $-25.8. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for KTRA
-
Value:-
EPS history for Kintara Therapeutics from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$9.27 | -64.07% |
| 2022 | -$25.80 | -67.75% |
| 2021 | -$80.00 | 83.91% |
| 2020 | -$43.50 | - |
View the highest EPS stocks
